Literature DB >> 1334087

Unique autolytic cleavage of human myeloperoxidase. Implications for the involvement of active site MET409.

K L Taylor1, J Pohl, J M Kinkade.   

Abstract

Myeloperoxidase (MPO) is a functionally important component of the normal human neutrophil host defense system. This enzyme possesses a dimeric structure composed of two heavy subunit (55-63 kDa)/light subunit (10-15 kDa) protomers, each of which is associated with a heme-like prosthetic group. In addition, MPO species of approximately 38 and 22 kDa have been reported by many different investigators, but their nature and mode of origin are not understood. In the present study, we demonstrate that when MPO is heated under nonreducing, denaturing conditions, these two species are produced via a novel autolytic cleavage of the heavy subunit. The 38-kDa species was isolated by fast-protein liquid chromatography and identified by sequencing as the carboxyl-terminal portion of the heavy subunit, and the cleavage was shown to occur exclusively between Met409 and Pro410. In order to further characterize this unusual cleavage reaction, the 22-kDa species was digested with endoproteinase Asp-N, and the peptide corresponding to its carboxyl terminus was isolated and analyzed by sequencing and mass spectrometry. These data indicated that during cleavage of the heavy subunit, Met409 was converted to homoserine lactone. Thus, the cleavage appeared to formally resemble the cyanogen bromide-dependent cleavage of Met-X peptide bonds. Recent x-ray crystallographic data for canine MPO have indicated that Met409 is in close proximity to the heme-like prosthetic group of MPO. Our studies suggest that interaction of Met409 with this group leads to the formation of a methionyl sulfonium derivative which undergoes intramolecular rearrangement with subsequent peptide cleavage under nonreducing conditions. This derivative may be, at least in part, responsible for the unusual spectral characteristics and enzymatic properties of the enzyme. The primary structure of the 22-kDa MPO species is also reported, and direct evidence is provided for asparagine-linked oligosaccharide moieties at two of the three predicted glycosylation sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.

Authors:  Jiansheng Huang; Forrest Smith; Peter Panizzi
Journal:  Arch Biochem Biophys       Date:  2014-03-13       Impact factor: 4.013

2.  Inactivation of myeloperoxidase by benzoic acid hydrazide.

Authors:  Jiansheng Huang; Forrest Smith; Jennifer R Panizzi; Douglas C Goodwin; Peter Panizzi
Journal:  Arch Biochem Biophys       Date:  2015-02-14       Impact factor: 4.013

3.  Selective identification and quantitative analysis of methionine containing peptides by charge derivatization and tandem mass spectrometry.

Authors:  Gavin E Reid; Kade D Roberts; Richard J Simpson; Richard A J O'Hair
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

4.  Identification of glutamate 344 as the catalytic residue in the active site of pig heart CoA transferase.

Authors:  J C Rochet; W A Bridger
Journal:  Protein Sci       Date:  1994-06       Impact factor: 6.725

5.  Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver.

Authors:  K E Brown; E M Brunt; J W Heinecke
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants.

Authors:  K Tomizawa; E Mine; A Fujii; Y Y Ohashi; S Yamagoe; Y Hashimoto; A Ishida-Okawara; M Ito; M Tanokura; T Yamamoto; Y Arimura; T Nagasawa; S Mizuno; K Suzuki
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

7.  Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.

Authors:  Wanjing Ding; Hiroyuki Shimada; Lin Li; Rahul Mittal; Xiaokun Zhang; Koichi Shudo; Qiaojun He; Nemani V Prasadarao; Lingtao Wu
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

8.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  A polysomal ribonuclease involved in the destabilization of albumin mRNA is a novel member of the peroxidase gene family.

Authors:  E Chernokalskaya; A N Dubell; K S Cunningham; M N Hanson; R E Dompenciel; D R Schoenberg
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

10.  Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.

Authors:  M Segelmark; B Baslund; J Wieslander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.